David J. HellerCalled to the bar: 1996 (ON) Partner Phone: 416-868-1482 Ext: 231 Fax: 416-362-0823 | Profile | David Heller is a partner of Ridout & Maybee LLP in the firm's Toronto office. His practice specializes in the areas of pharmaceuticals, biotechnology, and chemistry. Prior to commencing his legal career, David conducted physiology research for the Department of National Defence, and transplantation research for Toronto's Sunnybrook Medical Centre. He was also Assistant Science Policy Advisor to the Ontario Minister of Labour. David has been recognized as a leading IP lawyer in the Chambers Global Guide 2012, in which he was praised as "commercially aware, to the point and easy to get along with". | | Education | B.Sc. (Honours Biology/Chemistry), 1989, University of Waterloo; LL.B., 1994, University of Toronto; Barrister & Solicitor, Province of Ontario, 1996; Registered Patent Agent, Canada, 1997; Registered Trademark Agent, Canada, 1997 | | Memberships | Intellectual Property Institute of Canada (IPIC), Associate; IPIC Biotechnology Legislation Committee (Toronto Biotechnology Initiative); American Intellectual Property Law Association (AIPLA); International Federation of Industrial Property Attorneys (FICPI Biotech Committee); International Association for the Protection of Industrial Property (AIPPI); Guest lecturer for the University of Toronto Masters of Biotechnology Program; Osgoode Hall Law School, York University (Instructor, Structuring, Negotiating and Drafting Intellectual Property Licensing Agreements). | | Areas of Practice | Patents; Trademarks; Copyright; Industrial Designs; Trade Secrets; Licensing; Biotechnology & Pharmaceutical Law | | Published Works | Heller D. & Agha, K. “Deep into the Genome; A Roundtable Discussion on IP, Patenting, and Personalized Medicine” BioBusiness, pp. 10-12, July/August 2012; Heller, D. & Lee, J. “Amazon Finally Wins”, Canadian Lawyer InHouse, Vol. 7, Issue 3, June/July 2012; Heller, D. & Komarnicki, V. "Canada: Bar Raised for Attacking Patent Validity in Canada; Duty of Candour Narrowed", Mondaq, December 19, 2011; Heller, D. & Lee, J. "Privilege continues to evade patent agents", The Lawyers Weekly, September 17, 2010; Heller, D. & Anand, N. "Functional Pharma Claim Flawed, Finds Federal Court of Canada", APLF IP Law Bugle, June 2010; Heller, D. & Boulakia, C. “Beware Of What Your Canadian Patent Lawyer Is Saying”, APLF IP Law Bugle, March 2010; Heller, D. & Roach M. The Role of Subsequent Entry Biologics - Intellectual Property 2008, XIV(2), 854-858; David Heller and Adrian Zahl, “Proposed regulations to adjust generic balance,” Managing Intellectual Property (Focus- Life Science: Canada), March 2005; Heller, DJ and JD Wilson, “Harvard Mouse Trapped: Transgenic higher life forms not patentable in Canada”. Carswell: Legal Alert, 21(11):82-85, 2003; Heller, DJ, “Canada Rules That Transgenic Animals are Nonpatentable”. Genetic Engineering News, 23(2): 6, 59, 60, 2003; Heller, DJ, “Court allows patent on Harvard Mouse”. Law Times, August 21, 2000; Heller, DJ, “Will patents on plants be detrimental to the developing world.” Law Times, July 17, 2000 | | Honour/Awards | Named as a Leading Canadian Intellectual Property Lawyer in the Chambers Global 2013 Guide to the World's Leading Lawyers. | | Website Link | http://www.ridoutmaybee.com/ |
|
|